The global Charcot-Marie-Tooth disease treatment market is projected to experience significant development in the coming years, driven by factors such as an rising prevalence of the disorder, advancements in therapy, and expanding healthcare investment. The market is divided by classification of therapy, usage, distribution channel, and geography.